Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
111.64B | 105.20B | 106.17B | 95.71B | 65.83B | 57.71B | Gross Profit |
62.28B | 57.27B | 54.17B | 45.19B | 28.36B | 21.40B | EBIT |
38.56B | 33.42B | 32.29B | 26.64B | 11.34B | 4.62B | EBITDA |
44.39B | 36.80B | 39.10B | 32.48B | 17.59B | 10.79B | Net Income Common Stockholders |
27.89B | 21.38B | 20.68B | 16.67B | 5.33B | 2.73B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
40.12B | 37.41B | 29.29B | 29.36B | 20.53B | 13.78B | Total Assets |
161.04B | 138.02B | 126.38B | 127.41B | 95.20B | 86.28B | Total Debt |
21.12B | 21.73B | 19.71B | 19.43B | 15.48B | 17.33B | Net Debt |
-19.00B | -15.68B | -9.57B | -9.93B | -5.05B | 3.55B | Total Liabilities |
64.25B | 53.06B | 52.61B | 63.27B | 41.90B | 36.71B | Stockholders Equity |
96.79B | 84.95B | 72.89B | 63.73B | 53.30B | 49.57B |
Cash Flow | Free Cash Flow | ||||
0.00 | 16.52B | 9.55B | 20.55B | 10.45B | 6.61B | Operating Cash Flow |
0.00 | 27.46B | 21.34B | 25.80B | 13.19B | 9.66B | Investing Cash Flow |
0.00 | -10.87B | -9.45B | -12.43B | -2.47B | -3.89B | Financing Cash Flow |
0.00 | -10.34B | -12.54B | -5.78B | -4.26B | -3.60B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
64 Neutral | ¥335.78B | 11.97 | 2.99% | 12.03% | 49.56% | ||
61 Neutral | $11.29B | 10.07 | -7.05% | 2.96% | 7.47% | -10.75% | |
$2.18B | 18.01 | 13.42% | 3.91% | ― | ― | ||
$1.98B | 7.87 | 9.28% | 4.19% | ― | ― | ||
$1.91B | 25.16 | -0.56% | 3.84% | ― | ― | ||
$2.40B | 860.91 | 0.43% | 0.60% | ― | ― | ||
64 Neutral | ¥294.88B | 125.77 | 3.78% | 6.77% | 33087.95% |
Dexerials Corporation has been recognized for the fifth consecutive year as a Health and Productivity Management Organization 2025, highlighting its commitment to employee health and strategic management practices. The company has implemented initiatives like a health point system and team awards to promote physical and mental well-being, aiming to enhance employee capabilities and maintain a healthy work environment.
Dexerials Corporation’s 2024 Integrated Report has been recognized as an ‘Excellent Integrated Report’ by asset managers of the Government Pension Investment Fund. This recognition highlights Dexerials’ strategic focus on sustainability and its medium- to long-term growth plans, which align with its purpose of empowering evolution by connecting people and technology. The report emphasizes a future-oriented approach, detailing the company’s growth strategy, sustainability goals, and key ESG issues, thereby enhancing stakeholder understanding and corporate value.
Dexerials Corporation has announced the commencement of constructing a system utilizing generative AI to create innovative ideas for new product uses. This initiative aims to enhance Dexerials’ product development capabilities by efficiently matching market needs with the company’s technological assets, thereby accelerating the development of next-generation products and contributing to sustainable growth and corporate value enhancement.
Dexerials Corporation received the ‘Special Award’ at the 1st Intellectual Property and Intangible Asset Governance Awards, highlighting its leadership in intellectual property and intangible asset governance. The company is committed to enhancing corporate value through proactive intellectual property management, integrating technology and human resources, and fostering sustainable growth. By investing in intellectual property education and transparent disclosure of its activities, Dexerials aims to strengthen its competitive position and stakeholder engagement.